Hyderabad Telangana, India

Kailas Khomane

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2019.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kailas Khomane: Innovator in Pharmaceutical Compositions

Introduction

Kailas Khomane is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of acne. His innovative work has led to the development of effective pharmaceutical compositions that are beneficial for patients in need.

Latest Patents

Kailas Khomane holds a patent for "Pharmaceutical compositions for treating acne." This patent relates to compositions that comprise retinoic acid or its derivatives, such as isotretinoin. The application also details processes for preparing these compositions and provides methods for treating acne by administering the pharmaceutical composition to patients.

Career Highlights

Kailas Khomane is currently associated with Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company. His work at Dr. Reddy's has allowed him to focus on innovative solutions in the pharmaceutical industry, contributing to advancements in acne treatment.

Collaborations

Kailas has collaborated with notable coworkers, including Yogesh Bapurao Pawar and Saurabh Srivastava. These collaborations have fostered a creative environment that encourages innovation and the development of new pharmaceutical solutions.

Conclusion

Kailas Khomane's contributions to the field of pharmaceuticals, particularly in acne treatment, highlight his role as an innovator. His patent and work at Dr. Reddy's Laboratories demonstrate his commitment to improving patient care through effective pharmaceutical compositions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…